Putting It All Together: FHLC May Be Valued at $77
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 02 2025
0mins
Source: NASDAQ.COM
ETF Analyst Target Price: The Fidelity MSCI Health Care Index ETF (FHLC) has an implied analyst target price of $76.76 per unit, indicating an 11.75% upside from its recent trading price of $68.69.
Notable Holdings with Upside: Key underlying holdings of FHLC, such as Nutex Health Inc (NUTX), Twist Bioscience Corp (TWST), and Merit Medical Systems, Inc. (MMSI), show significant potential for price increases based on analyst targets, with NUTX having a target price 141.86% higher than its current price.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NUTX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NUTX
Wall Street analysts forecast NUTX stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 193.540
Low
230.00
Averages
265.00
High
300.00
Current: 193.540
Low
230.00
Averages
265.00
High
300.00
About NUTX
Nutex Health Inc. is a healthcare management and operations company. The Company operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates over 27 facilities in 12 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization, it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
U.S. Stocks Close Lower on Friday, Chipmakers Weigh on Market
- Market Decline: The S&P 500 and Nasdaq 100 fell by 0.05% and 1.09% respectively on Friday, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which could undermine investor confidence.
- Chipmaker Sell-off: The significant drop in Samsung Electronics and SK Hynix shares led to a more than 5% decline in South Korea's Kospi Index, triggering a global downturn in semiconductor stocks and exacerbating market uncertainty.
- Oil Price Impact: WTI crude oil prices fell over 3% to a four-month low on Friday, which helps lower inflation expectations and supports the stock market, but also reflects potential slowdowns in global economic growth.
- Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward by 0.6 to 49.5, although still below the expected 50.0, indicating a cautious consumer outlook that may affect future spending.
See More
US Stock Market Under Pressure as Chip Stocks Plummet
- Market Weakness: The S&P 500 and Nasdaq 100 indices fell by 0.07% and 0.75%, respectively, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which may lead to declining investor confidence.
- Chip Stock Plunge: The significant sell-off of Samsung Electronics and SK Hynix caused the South Korean Kospi index to drop over 5%, triggering a global decline in chip stocks and exacerbating market uncertainty.
- Oil Price Decline Impact: WTI crude oil prices fell by more than 3%, easing inflation expectations and supporting stocks; however, the recovery of crude exports to 75% of pre-war levels may influence future market dynamics.
- Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward to 49.5, although still below the expected 50.0, reflecting cautious consumer attitudes towards the economic outlook, which could affect retail and consumer-related stocks.
See More
US Stocks Decline as Chipmakers Weigh on Market
- Market Decline: The S&P 500 index fell by 0.54% and the Nasdaq 100 dropped by 1.38%, both hitting two-week lows, indicating a weak market sentiment primarily driven by the poor performance of chipmakers, which significantly pressured the overall market.
- Chipmaker Sell-off: The sharp decline in Samsung Electronics and SK Hynix led to a more than 5% drop in South Korea's Kospi index, triggering a global sell-off in chip stocks and exacerbating investor concerns regarding the tech sector.
- Oil Price Impact: WTI crude oil prices fell by over 3% today, which not only eased inflation expectations but also lowered bond yields; however, the overall market remained under pressure due to weak stock performance.
- Software Stock Resilience: Despite the overall market downturn, software stocks like ServiceNow and Salesforce rose by over 6% and 4% respectively, somewhat limiting the market's downside, reflecting ongoing investor confidence in the software sector.
See More
Nutex Health Executives Accused of Breaching Fiduciary Duties
- Investigation Launched: Kuehn Law, PLLC is investigating whether Nutex Health, Inc. executives breached their fiduciary duties to shareholders, with allegations that could expose the company to significant legal risks.
- False Statements Revealed: A federal securities lawsuit claims that Nutex Health failed to disclose fraudulent activities associated with its partnership with HaloMD, raising doubts about the sustainability of the company's revenues and potentially impacting the accuracy of future financial reports.
- Internal Control Deficiencies: The company is accused of overstating its ability to remediate material weaknesses in its internal controls over financial reporting, leading to difficulties in accounting for stock-based compensation obligations and increasing the risk of delays in filing financial reports.
- Shareholder Rights at Risk: Due to these issues, Nutex Health's business prospects were overstated, resulting in materially false and misleading public statements at all relevant times, prompting shareholders to contact legal counsel promptly to protect their rights.
See More
Nutex Health NUTX Q1 2025 Earnings Transcript
See More
Nutex Health NUTX Q2 2025 Earnings Transcript
See More
U.S. Stocks Close Lower on Friday, Chipmakers Weigh on Market
- Market Decline: The S&P 500 and Nasdaq 100 fell by 0.05% and 1.09% respectively on Friday, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which could undermine investor confidence.
- Chipmaker Sell-off: The significant drop in Samsung Electronics and SK Hynix shares led to a more than 5% decline in South Korea's Kospi Index, triggering a global downturn in semiconductor stocks and exacerbating market uncertainty.
- Oil Price Impact: WTI crude oil prices fell over 3% to a four-month low on Friday, which helps lower inflation expectations and supports the stock market, but also reflects potential slowdowns in global economic growth.
- Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward by 0.6 to 49.5, although still below the expected 50.0, indicating a cautious consumer outlook that may affect future spending.
See More
US Stock Market Under Pressure as Chip Stocks Plummet
- Market Weakness: The S&P 500 and Nasdaq 100 indices fell by 0.07% and 0.75%, respectively, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which may lead to declining investor confidence.
- Chip Stock Plunge: The significant sell-off of Samsung Electronics and SK Hynix caused the South Korean Kospi index to drop over 5%, triggering a global decline in chip stocks and exacerbating market uncertainty.
- Oil Price Decline Impact: WTI crude oil prices fell by more than 3%, easing inflation expectations and supporting stocks; however, the recovery of crude exports to 75% of pre-war levels may influence future market dynamics.
- Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward to 49.5, although still below the expected 50.0, reflecting cautious consumer attitudes towards the economic outlook, which could affect retail and consumer-related stocks.
See More
US Stocks Decline as Chipmakers Weigh on Market
- Market Decline: The S&P 500 index fell by 0.54% and the Nasdaq 100 dropped by 1.38%, both hitting two-week lows, indicating a weak market sentiment primarily driven by the poor performance of chipmakers, which significantly pressured the overall market.
- Chipmaker Sell-off: The sharp decline in Samsung Electronics and SK Hynix led to a more than 5% drop in South Korea's Kospi index, triggering a global sell-off in chip stocks and exacerbating investor concerns regarding the tech sector.
- Oil Price Impact: WTI crude oil prices fell by over 3% today, which not only eased inflation expectations but also lowered bond yields; however, the overall market remained under pressure due to weak stock performance.
- Software Stock Resilience: Despite the overall market downturn, software stocks like ServiceNow and Salesforce rose by over 6% and 4% respectively, somewhat limiting the market's downside, reflecting ongoing investor confidence in the software sector.
See More
Nutex Health Executives Accused of Breaching Fiduciary Duties
- Investigation Launched: Kuehn Law, PLLC is investigating whether Nutex Health, Inc. executives breached their fiduciary duties to shareholders, with allegations that could expose the company to significant legal risks.
- False Statements Revealed: A federal securities lawsuit claims that Nutex Health failed to disclose fraudulent activities associated with its partnership with HaloMD, raising doubts about the sustainability of the company's revenues and potentially impacting the accuracy of future financial reports.
- Internal Control Deficiencies: The company is accused of overstating its ability to remediate material weaknesses in its internal controls over financial reporting, leading to difficulties in accounting for stock-based compensation obligations and increasing the risk of delays in filing financial reports.
- Shareholder Rights at Risk: Due to these issues, Nutex Health's business prospects were overstated, resulting in materially false and misleading public statements at all relevant times, prompting shareholders to contact legal counsel promptly to protect their rights.
See More
Nutex Health NUTX Q1 2025 Earnings Transcript
See More
Nutex Health NUTX Q2 2025 Earnings Transcript
See More
